UNION KOREA PHARM CO.,Ltd Logo

UNION KOREA PHARM CO.,Ltd

Researches, develops, manufactures, and distributes prescription drugs.

080720 | KO

Overview

Corporate Details

ISIN(s):
KR7080720006
LEI:
Country:
South Korea
Address:
강원도 원주시 문막읍 문막공단길 246, 원주시

Description

UNION KOREA PHARM CO.,Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and distribution of prescription drugs. The company produces a range of specialty medicines in various formulations, including solid dosage forms, liquid injections, and powders. Its product portfolio addresses therapeutic areas such as neoplasms, immune system diseases, anti-inflammatory analgesics, antibiotics, and skeletal muscle relaxants. The company emphasizes strict quality control throughout the entire production cycle, from raw materials to shipping, to ensure its products meet Good Manufacturing Practice (GMP) standards. It operates in both domestic and international markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-17 00:00
기타경영사항(자율공시) (M&A 조건부 투자계약 체결)
Korean 5.5 KB
2025-09-16 00:00
회생절차개시결정
Korean 8.0 KB
2025-09-16 00:00
주권매매거래정지기간변경 (회생절차 개시결정)
Korean 5.4 KB
2025-09-15 00:00
횡령ㆍ배임혐의진행사항
Korean 6.4 KB
2025-09-11 00:00
사채원리금미지급발생
Korean 8.7 KB
2025-09-10 00:00
[기재정정]주요사항보고서(회생절차개시신청)
Korean 8.8 KB
2025-09-09 00:00
주요사항보고서(회생절차개시신청)
Korean 5.5 KB
2025-09-09 00:00
주권매매거래정지기간변경 (회생절차 개시신청)
Korean 5.4 KB
2025-09-02 00:00
횡령ㆍ배임혐의진행사항
Korean 6.4 KB
2025-09-01 00:00
횡령ㆍ배임혐의진행사항
Korean 7.5 KB
2025-09-01 00:00
횡령ㆍ배임혐의진행사항
Korean 7.4 KB
2025-08-29 00:00
횡령ㆍ배임혐의진행사항
Korean 7.1 KB
2025-08-29 00:00
횡령ㆍ배임혐의진행사항
Korean 6.9 KB
2025-08-13 00:00
반기보고서 (2025.06)
Korean 1.5 MB
2025-08-13 00:00
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 12.3 KB

Automate Your Workflow. Get a real-time feed of all UNION KOREA PHARM CO.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for UNION KOREA PHARM CO.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for UNION KOREA PHARM CO.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.